Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Hydrolases
Patent
1987-12-17
1990-05-22
Hearn, Brian E.
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
Hydrolases
A61K 3748
Patent
active
049276298
ABSTRACT:
Certain substances are provided which have the ability to relax smooth vascular muscle, having an endothelial lining, when administered in vitro or by intravenous injection. Examples of useful substances which are pharmaceutically-acceptable include phospholipase A.sub.2 (PLA.sub.2) and certain lysolecithins. The concentration required is at least about 3 units of PLA.sub.2 and at least about 10.sup.-5 Molar lysolecithin. The lysolecithins are dissolved in a suitable solvent, such as dimethyl sulfoxide, for injection. Alternatively, phospholipase A.sub.2 is administered directly. The resulting solutions should have a pharmacologically-effective amount of the substance dissolved therein. Importantly, the body does not develop a tolerance to the lysolecithin.
REFERENCES:
patent: 4699919 (1987-10-01), Follet et al.
patent: 4788304 (1988-11-01), Marshall et al.
patent: 4826821 (1989-05-01), Clements
Chemical Abstracts, 101:83569v; 86:37623g; 76:121521y; 108:129304e; 108:202449n; 110:5309g; 109:71073f.
Rogausch, H., Research Experimental Medicine, (173) (1) (1978), pp. 9-16, abstract only.
Griffis Andrew
Hearn Brian E.
Huntington Medical Research Institutes
LandOfFree
Relaxation of smooth vascular muscle does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Relaxation of smooth vascular muscle, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Relaxation of smooth vascular muscle will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2133527